NIH ME/CFS Telebriefing
NIH’s next ME/CFS Advocacy Call will be held on May 1, 2023 from 12:00 – 1:00 pm ET. The webinar will include updates from NIH on ME/CFS-related research activities and […]
NIH Awards $9.5M Grant to Study ME/CFS
The Cornell Center for Enervating Neuroimmune Disease has received a five-year grant of nearly $10 million from the National Institutes of Health’s National Institute of Allergy and Infectious Disease, enriching […]
Watch now! “Long Covid: What Will it Take to Accelerate Therapeutic Progress?”
Solve M.E. and BIO co-hosted a timely and informative event examining the emerging research in Long Covid and the existing body of data in other post-infection diseases such as ME/CFS. […]
New Studies Point to a Signature for ME/CFS: Will They Lead to Widely Used Diagnostic Tests?
By Oved Amitay, Solve M.E. President and CEO Three studies were published last week, describing incredibly intriguing data, each pointing to specific biomarkers that can help to identify people with […]
New Findings Alert! NIH-Funded Studies Link Altered Gut Microbes to ME/CFS
Recently released papers with findings from two National Institutes of Health-funded studies by the Center for Solutions for ME/CFS & The Jackson Laboratory indicate that microbiome changes may be a […]
Solve, BIO Online Conference Invites Biotech to Join In Fighting Long Covid
This article by Tom Popper originally appeared on Bio.com. While research into Long Covid is offering clues to causes and potential targets for treatment, defeating this debilitating condition, which impacts […]
Thank you! Your support fuels big plans!
What a way to close out 2022! We are so grateful for your generosity throughout the year, and especially during our recent year-end campaign. Thank you for helping us surpass […]
Understanding the Biomarkers of PASC (otherwise known as Long Covid)
The RECOVER Research Review (R3) Seminar Series will host a panel discussion titled, “Understanding the Biomarkers of PASC” on Tuesday, November 8th 12:00-1:30 PM EDT featuring: Michael Peluso, MD, University […]
RECOVER Study of Paxlovid to Treat Long Covid Begins January 2023, Has Implications for ME/CFS
The National Institutes of Health (NIH) announced that the use of Paxlovid to treat Long Covid will be the first treatment to be studied by its $1 billion RECOVER Initiative. […]
Leveraging EHR/Real World Data to Understand PASC
Join the National Health Institutes (NIH) RECOVER Research Review (R3) Seminar Series, “Leveraging EHR/Real World Data to Understand PASC,” by registering here: http://ow.ly/sZep50Jg45C. The goal of the R3 Seminar Series is to […]
President Biden Signs FY22 Budget: Wins for ME/CFS and Long Covid
Support Research, Support Patients A recent survey from our friends at Research!America found that over 80% of Americans believe our government should fund “basic scientific research that advances the frontiers […]
Understanding Long COVID Across Communities of Color, Including Those Hardest Hit by COVID
The National Institutes of Health (NIH) is hosting a listening session, “Understanding Long COVID Across Communities of Color, Including Those Hardest Hit by COVID” on Friday 1/21 from 2PM – […]
